Moderna Inc. stock falls Tuesday, underperforms market

Shares of Moderna Inc. MRNA, -0.68% dropped 0.68% to $190.69 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP, +0.14% rising 0.14% to 11,095.11 and the Dow Jones Industrial Average DJIA, -1.14% falling 1.14% to 33,910.85. The stock’s fall snapped a two-day winning streak. Moderna Inc. closed $26.56 short of its 52-week high ($217.25), which the company reached on December 14th. The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson JNJ -0.62% fell 0.62% to $172.36 and Pfizer Inc. PFE, -3.70% fell 3.70% to $46.08. Trading volume (3.2 M) remained 2.2 million below its 50-day average volume of 5.4 M. Editor’s Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Leave a Comment

Your email address will not be published. Required fields are marked *